Terumo Co. (OTCMKTS:TRUMY – Get Free Report) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 22,000 shares, an increase of 27.9% from the December 31st total of 17,200 shares. Based on an average daily trading volume, of 181,400 shares, the days-to-cover ratio is currently 0.1 days.
Terumo Trading Down 4.5 %
Shares of TRUMY stock traded down $0.88 during trading hours on Friday, reaching $18.66. 910,883 shares of the stock traded hands, compared to its average volume of 154,783. The company has a quick ratio of 1.70, a current ratio of 2.94 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $27.63 billion, a PE ratio of 41.07 and a beta of 0.65. Terumo has a 1-year low of $14.06 and a 1-year high of $21.22. The business has a fifty day moving average price of $19.58 and a 200 day moving average price of $19.01.
Terumo (OTCMKTS:TRUMY – Get Free Report) last announced its earnings results on Thursday, November 7th. The company reported $0.13 earnings per share (EPS) for the quarter. The firm had revenue of $1.68 billion for the quarter.
Terumo Company Profile
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Read More
- Five stocks we like better than Terumo
- Utilities Stocks Explained – How and Why to Invest in Utilities
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- What Are Dividend Challengers?
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- 3 Best Fintech Stocks for a Portfolio Boost
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.